LFT Blog Singh

Mit Dr. Paul I. Singh

Der LFT Blog spricht die zunehmende Rolle der LFT in der klinischen Praxis an. Kuratiert vom Arzt Paul I. Singh, der bereits mehr als 3000 LFT Behandlungen durchgeführt hat, spricht der Blog eine Reihe von Themen an, die mit der Behandlung von Patienten zu tun haben, die unter Floater-Symptomen leiden. Dr. Singh arbeitet an der The Eye Centers of Racine & Kenosha in Wisconsin, USA. Er war der erste Augenarzt in Wisconsin und Illinois, der ein iStent Glaukomdrainageventil eingesetzt hat, und kürzlich an der Entwicklung von neuen Kontaktgläsern und Lasertechnologien mitgearbeitet hat, die bei Laser-Floater-Behandlungen zum Einsatz kommen.

Picking the Right Patient Helps the Learning Curve

by Dr. Paul I. Singh

When adopting a new procedure or technique, outcomes of the first few cases can shape the surgeon’s perspective of that procedure, and in turn, affect the willingness to continue performing the procedure. Take Laser Floater Treatment (LFT) for example; although this procedure has been attempted for many years, with new technology and new protocols/techniques, LFT has been reintroduced to the world of ophthalmology over the past 1-2 years. Because there have been changes to the YAG laser as well as technique, there is a learning curve.

Read more

When is a condition 'Bad Enough to Treat?'

by Dr. Paul I. Singh

In medicine, our decision to treat or not to treat a condition has been based on the risk-benefit ratio associated with the treatment. Basically, the higher the risk, the worse the symptoms usually have to be before the surgeon and patient are willing to perform the surgery. As technology has advanced, the risk associated with many procedures has generally decreased, subsequently leading to surgeons and patients opting to perform the procedure much earlier in the disease process.

Read more

Modern LFT. Does the data stack up?

by Dr. Paul I. Singh

In recent years, there has no doubt been an increased interest in modern laser floater treatment, LFT. Within the past five years since I began performing the procedure, more and more surgeons are now adopting LFT in their practices. Although the procedure may seem fairly new, surgeons may not realize that the use of a YAG laser to treat symptomatic floaters has been performed for many decades. So, why is this procedure only now starting to gain traction?

Read more

Can the Vitreous Help Explain the Unhappy Postop Cataract Patient?

by Dr. Paul I. Singh

Our cataract patients’ expectations have steadily increased as our surgical technique and IOL technology has advanced over the years. As a profession, we have focused a great deal of attention on the smallest detail during the entire process; pre-op, (including biometry, topography, OCT), to intraoperative tools and techniques (such as femtosecond assisted surgery, intra op aberrometry, and premium IOLs), to postop drop and capsule management.

Read more

Does Technology Define When a Condition is Worth Treating?

by Dr. Paul I. Singh

Historically, as a profession, we have created the perception that vitreous floaters (opacities) are a mere annoyance to our patients. A condition that, although many people complain of, does not cause a significant enough impact on quality of life and daily functioning to warrant treatment. Why is that? Why is it considered just an annoyance when patients often complain of difficulty driving, reading, or even working on a computer?

Read more
Welcome to Floater LFT Deutschland. Continue to Floater LFT Vereinigte Staaten von Amerika at floater-lft.comus/
Let's go!
Diese Webseite verwendet Cookies, um Ihnen den bestmöglichen Service zu gewährleisten.
Die Cookies speichern keinerlei persönliche Informationen. Mehr erfahren